Concord Biotech share news, announcements and annual reports
NSE: CONCORDBIOBSE: 543960Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,230.60.
30 Oct: open ₹1,224.30, high ₹1,272.40, low ₹1,215.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13,031 Cr496th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 46.14
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.61%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,03,69239.5% delivered
Concord Biotech has 156 announcements on record, routine notices left out; 7 in the 30 days to 30 Oct 2026, the latest on 28 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Concord Biotech quarterly results
The board met on 27 Oct 2026 to consider financial results
Notice filed 22 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Concord Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Concord Biotech financials, year by year
Annual reports3
- Annual report, year to Mar 20267 Jul 2026
- Annual report, year to Mar 202513 Aug 2025
- Annual report, year to Mar 20247 Jun 2024
Investor presentations14
- Investor Presentation27 Oct 2026
- Presentation1 Aug 2026
- Investor Presentation30 May 2026
- Investor Presentation11 Feb 2026
- Investor Presentation13 Nov 2025
9 earlier presentations
- Investor Presentation10 Aug 2025
- Investor Presentation30 May 2025
- Investor Presentation14 Feb 2025
- Investor Presentation11 Nov 2024
- Presentation10 Aug 2024
- Presentation27 May 2024
- Investor Presentation9 Feb 2024
- Investor Presentation8 Nov 2023
- Investor Presentation6 Sep 2023
Earnings calls27
- Link of Recording28 Oct 2026
- Transcript7 Aug 2026
- Link of Recording3 Aug 2026
- Transcript5 Jun 2026
- Link of Recording1 Jun 2026
22 earlier call documents
- Transcript18 Feb 2026
- Link of Recording12 Feb 2026
- Transcript19 Nov 2025
- Link of Recording15 Nov 2025
- Transcript18 Aug 2025
- Link of Recording11 Aug 2025
- Transcript6 Jun 2025
- Link of Recording30 May 2025
- Transcript21 Feb 2025
- Link of Recording14 Feb 2025
- Transcript19 Nov 2024
- Link of Recording12 Nov 2024
- Transcript20 Aug 2024
- Link of Recording12 Aug 2024
- Transcript4 Jun 2024
- Link of Recording28 May 2024
- Transcript16 Feb 2024
- Link of Recording9 Feb 2024
- Transcript16 Nov 2023
- Link of Recording9 Nov 2023
- Transcript13 Sep 2023
- Link of Recording7 Sep 2023
Concord Biotech share news and announcements
Newest first. Page 1 of 4.
Oct 2026
28 Oct · Analysts
27 Oct · Corporate action
27 Oct · Results
23 Oct · Analysts
22 Oct · Board meeting
Sep 2026
24 Sep · Meeting
19 Sep · Board meeting
17 Sep · Analysts
Aug 2026
21 Aug · Analysts
Jul 2026
31 Jul · Meeting
31 Jul · Results
28 Jul · Analysts
28 Jul · Board meeting
7 Jul · Corporate action
7 Jul · Meeting
Jun 2026
20 Jun · Business
19 Jun · Analysts
13 Jun · Analysts
May 2026
30 May · Results
26 May · Analysts
Apr 2026
2 Apr · Business
Feb 2026
26 Feb · Analysts
26 Feb
20 Feb · Analysts
20 Feb · Analysts
12 Feb · Analysts
11 Feb
11 Feb · Results
9 Feb · Legal
The exchange asked on 6 Feb 2026
6 Feb · Analysts
6 Feb · Board meeting
Dec 2025
18 Dec · Board meeting
Nov 2025
15 Nov · Analysts
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 28 Oct 2026Resultsdown 7.77%−7.7 pts vs Nifty 500market median −0.7% · volume 4.0× usual · delivery −13.1 pts against usual · The announcement
- 3 Aug 2026Resultsdown 0.44%−1.9 pts vs Nifty 500market median −0.7% · five sessions −3.9% (−5.0 pts vs Nifty 500) · volume 3.2× usual · delivery −5.6 pts against usual · The announcement
- 12 Feb 2026Resultsdown 1.28%−0.7 pts vs Nifty 500market median −0.7% · five sessions −7.7% (−7.1 pts vs Nifty 500) · volume 0.8× usual · delivery −24.8 pts against usual · The announcement
- 26 Dec 2025Board or managers changeddown 0.57%−0.3 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−1.1 pts vs Nifty 500) · volume 0.3× usual · delivery +10.2 pts against usual · The announcement
- 8 Dec 2025Board or managers changeddown 3.25%−2.0 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−2.3 pts vs Nifty 500) · volume 1.7× usual · delivery +26.2 pts against usual · The announcement
- 14 Nov 2025Resultsup 2.77%+2.7 pts vs Nifty 500market median −0.7% · five sessions −1.3% (−1.9 pts vs Nifty 500) · volume 2.0× usual · delivery −14.4 pts against usual · The announcement
- 11 Aug 2025Resultsup 0.38%−0.5 pts vs Nifty 500market median −0.7% · five sessions +2.3% (+0.1 pts vs Nifty 500) · volume 3.3× usual · delivery −2.8 pts against usual · The announcement
- 30 May 2025Dividendup 4.90%+5.2 pts vs Nifty 500market median 0.0% · five sessions +11.0% (+10.7 pts vs Nifty 500) · volume 5.9× usual · delivery −21.4 pts against usual · The announcement
- 14 May 2025Board or managers changedup 0.09%−0.6 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−0.6 pts vs Nifty 500) · volume 0.8× usual · delivery +14.0 pts against usual · The announcement
- 9 Aug 2024Resultsdown 2.01%−3.0 pts vs Nifty 500market median −0.7% · five sessions +3.1% (+1.5 pts vs Nifty 500) · volume 2.1× usual · delivery −18.3 pts against usual · The announcement
6 earlier announcements
- 24 May 2024Dividenddown 0.52%−0.5 pts vs Nifty 500market median 0.0% · five sessions −0.7% (+1.4 pts vs Nifty 500) · volume 1.4× usual · delivery +14.8 pts against usual · The announcement
- 23 May 2024Dividenddown 0.06%−1.2 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−0.9 pts vs Nifty 500) · volume 1.3× usual · delivery −15.8 pts against usual · The announcement
- 3 Oct 2023Board or managers changeddown 0.75%−0.5 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+6.6 pts vs Nifty 500) · volume 0.8× usual · delivery −10.5 pts against usual · The announcement
- 7 Sep 2023Resultsdown 2.22%−2.8 pts vs Nifty 500market median −0.7% · five sessions +1.4% (0.0 pts vs Nifty 500) · delivery −7.6 pts against usual · The announcement
- 28 Aug 2023Board or managers changedup 2.46%+2.1 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−1.8 pts vs Nifty 500) · The announcement
- 21 Aug 2023Board or managers changedup 0.77%+0.2 pts vs Nifty 500market median 0.0% · five sessions +3.3% (+2.9 pts vs Nifty 500) · The announcement
Concord Biotech results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.